000			01864 a2200517 4500
005			20250516113755.0
264		0	_c20130625
008			201306s 0 0 eng d
022			_a1873-5576
040			_aNLM _beng _cNLM
100	1		_aKarra, Nour
245	0	0	_aSafety and proof-of-concept efficacy of inhaled drug loaded nano- and immunonanoparticles in a c-Raf transgenic lung cancer model. _h[electronic resource]
260			_bCurrent cancer drug targets _cJan 2013
300			_a11-29 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdministration, Inhalation
650	0	4	_aAnimals
650	0	4	_aAntibodies, Immobilized _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Neoplasm _xadministration & dosage
650	0	4	_aAntigens, Neoplasm _xmetabolism
650	0	4	_aAntineoplastic Agents, Phytogenic _xadministration & dosage
650	0	4	_aCell Adhesion Molecules _xantagonists & inhibitors
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Delivery Systems _xadverse effects
650	0	4	_aEpithelial Cell Adhesion Molecule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLung _xdrug effects
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Transgenic
650	0	4	_aNanoparticles _xadministration & dosage
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aPalmitates _xadministration & dosage
650	0	4	_aProto-Oncogene Proteins c-raf _xgenetics
650	0	4	_aRandom Allocation
650	0	4	_aSurface Properties
650	0	4	_aSurvival Analysis
700	1		_aNassar, Taher
700	1		_aLaenger, Florian
700	1		_aBenita, Simon
700	1		_aBorlak, Juergen
773	0		_tCurrent cancer drug targets _gvol. 13 _gno. 1 _gp. 11-29
999			_c22152676 _d22152676